Description
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Purity | ≥95% |
|---|---|
| Formula | C51H85N13O21 |
| Formula Wt. | 1216.32 |
| Synonym | IL-6R |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bosze S, Hudecz F, Igaz P, et al. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells. Biol Chem. 2003 Mar;384(3):409-21. PMID: 12715892.
Sulfonylurea; SUR1 antagonist.
5-HT2A antagonist, potential α1-adrenergic ant...
R,R enantiomer of formoterol; β2-adrenergic an...
Benzimidazole; microtubule polymerization inhib...
Peptide, derivative of AT I, cleavage product o...
Efflux pump inhibitor
Thienylbutyl ITC analog.
Oxazolidinone; protein synthesis inhibitor.
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
Diterpene alkaloid found in Aconitum; voltage-g...
α2-adrenergic and imidazoline-1 antagonist, AT...
Macrolide; vacuolar H+-ATPase inhibitor.
Synthetic progestogen; PR agonist.
Butyrophenone; σ2 agonist, α1-adrenergic, D2,...
GSK-3β inhibitor.
Valsartan impurity
Endogenous purine nucleotide base, required for...
Synthetic derivative of vasicine, mucolytic.
USP1 inhibitor
Selective CDK2 inhibitor.